EX-FILING FEES 4 d314495dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

CALCULATION OF REGISTRATION FEE

Form S-8

(Form Type)

Aura Biosciences, Inc.

(Exact name of registrant as specified in its charter)

Newly Registered Securities

 

Security Type   

Security

Class

Title

  

Fee

Calculation

Rule

   Amount
Registered(1)
  Proposed
Maximum
Offering
Price Per
Share(2)
  

Maximum
Aggregate

Offering

Price

  

Fee

Rate

   Amount of
Registration
Fee
Equity    Common Stock,
$0.00001 par value per share,
2021 Stock Option and Incentive
Plan
   Rule 457(c) and
Rule 457(h)
   1,460,582(3)   $21.06    $30,759,856.92    $0.0000927    $2,851.44
Equity    Common Stock, $0.00001 par
value per share, 2021 Employee
Stock Purchase Plan
   Rule 457(c) and
Rule 457(h)
   292,116(4)   $21.06    $6,151,962.96    $0.0000927    $570.29
Total Offering Amounts        $36,911,819.88        
Total Fees Previously Paid                 
Total Fee Offsets                 
Net Fee Due                  $3,421.73

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, $0.00001 par value per share (the “Common Stock”), which become issuable under the under the 2021 Stock Option and Incentive Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “2021 ESPP”) by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock.

 

(2)

The price of $21.06 per share, which is the average of the high and low sale prices of the common stock on the Nasdaq Global Market on March 18, 2022, is set forth solely for purposes of calculating the registration fee pursuant to Rules 457(c) and (h) of the Securities Act.

 

(3)

Represents an automatic increase to the number of shares available for issuance under the 2021 Plan, of 1,460,582 effective as of January 1, 2022. Shares available for issuance under the 2021 Plan were previously registered on registration statements on Form S-8 filed with the Securities and Exchange Commission on October 29, 2022 (File No. 333-260589).

 

(4)

Represents an automatic increase to the number of shares available for issuance under the 2021 ESPP, of 292,116 effective as of January 1, 2022. Shares available for issuance under the 2021 ESPP were previously registered on registration statements on Form S-8 filed with the Securities and Exchange Commission on October 29, 2022 (File No. 333-260589).